|
|
||||||||
Address correspondence and reprint requests to Dr. Eric J. Sorenson, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail: Sorenson.eric{at}mayo.edu
Objective: To assess the reliability of strength testing techniques among centers investigating patients with amyotrophic lateral sclerosis.
Methods: The authors compared test reliability in manual muscle testing (MMT) and maximal voluntary isometric contraction (MVIC) scores among institutions and test validity by comparing change over time between MMT and MVIC. The authors examined 63 subjects at 3-month intervals for 12 months. At enrollment and at 6 months, two physical therapists each examined the subjects twice. MMT scores were calculated as modifications of the Medical Research Council scale. MVIC scores were generated as standardized megascores. Intraclass correlation coefficients and coefficients of variation compared reproducibility, and Pearson correlation coefficients compared change over time. The power of each measure to detect disease progression over time was assessed by estimating coefficients of variation for the average change.
Results: Reproducibility between MVIC and MMT was equivalent. Sensitivity to detect progressive weakness and power to detect this change, however, favored MMT, an effect largely accounted for by the number of muscles sampled.
Conclusions: In multicentered trials, uniformly trained physical therapists reproducibly and accurately measure strength by both MMT and MVIC. The authors found MMT to be the preferred measure of global strength because of its better Pearson correlation coefficients, essentially equivalent reproducibility, and more favorable coefficient of variation.
Received December 13, 2001. Accepted in final form August 27, 2003.
*Members of the Great Lakes ALS Study Group are listed in the Appendix on page 1506.
This article has been cited by other articles:
![]() |
J. Montes, A. M. Gordon, S. Pandya, D. C. De Vivo, and P. Kaufmann Clinical Outcome Measures in Spinal Muscular Atrophy J Child Neurol, August 1, 2009; 24(8): 968 - 978. [Abstract] [PDF] |
||||
![]() |
P. H. Gordon, B. Cheng, I. B. Katz, H. Mitsumoto, and L. P. Rowland Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS Neurology, June 2, 2009; 72(22): 1948 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.M. Mezzapesa, A. Ceccarelli, F. Dicuonzo, A. Carella, M.F. De Caro, M. Lopez, V. Samarelli, P. Livrea, and I.L. Simone Whole-Brain and Regional Brain Atrophy in Amyotrophic Lateral Sclerosis AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 255 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Montes, G. Levy, S. Albert, P. Kaufmann, R. Buchsbaum, P. H. Gordon, and H. Mitsumoto Development and evaluation of a self-administered version of the ALSFRS-R. Neurology, October 10, 2006; 67(7): 1294 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Leigh and H. Mitsumoto MMT vs MVIC: Low-tech scores high? Neurology, December 9, 2003; 61(11): 1472 - 1473. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |